Literature DB >> 23044361

[1st National Meeting of Multidisciplinary Work in Oncogeriatrics: expert consensus document].

Maite Antonio1, Juana Saldaña, Francesc Formiga, Alicia Lozano, Jesús González-Barboteo, Paz Fernández, Fernando Arias, Lorena Arribas, Elisabeth Barbero, María del Mar Bescós, Maria Jesús Boya, Pilar Bueso, Ana Casas, Emma Dotor, Eduard Fort, Pilar García-Alfonso, Ismael Herruzo, Mireia Llonch, Germà Morlans, Maria Teresa Murillo, Gustavo Ossola, Inma Peiró, Fabiola Saiz, Javier Sanz, José Antonio Serra, Jordi Trelis, Antonio Yuste.   

Abstract

On 2nd of June 2011 the Institut Català d' Oncologia l'Hospitalet--Hospital Duran i Reynals hosted the first Meeting of Multidisciplinary Work in Oncogeriatrics. The reason for the meeting, which follows on from an initiative of the Medical Societies of Radiotherapy, Oncology, Geriatrics and Gerontology and Palliative Care and Medical Oncology, was to initiate a joint line of work among the different specialties that generally take part in the handling of the elderly patient suffering from oncologic pathologies. This document summarises the different subjects covered during the Meeting.
Copyright © 2012 SEGG. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23044361     DOI: 10.1016/j.regg.2012.05.006

Source DB:  PubMed          Journal:  Rev Esp Geriatr Gerontol        ISSN: 0211-139X


  2 in total

Review 1.  Cancer and aging in Ibero-America.

Authors:  E Soto-Perez-de-Celis; R Cordoba; R Gironés; T Karnakis; I Paredero; Y Chavarri-Guerra; A P Navarrete-Reyes; J A Avila-Funes
Journal:  Clin Transl Oncol       Date:  2018-02-12       Impact factor: 3.405

2.  Geriatric oncology in Spain: survey results and analysis of the current situation.

Authors:  R Gironés; I Morilla; C Guillen-Ponce; M D Torregrosa; I Paredero; E Bustamante; S Del Barco; G Soler; B Losada; L Visa; E Llabrés; B Fox; J L Firvida; R Blanco; M Antonio; F Aparisi; M Pi-Figueras; E Gonzalez-Flores; M J Molina-Garrido; J Saldaña
Journal:  Clin Transl Oncol       Date:  2017-12-11       Impact factor: 3.405

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.